✦ LIBER ✦

DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study

✍ Scribed by PL Barratt; MT Seymour; SP Stenning; I Georgiades; C Walker; K Birbeck; P Quirke

Book ID: 117281999
Publisher: The Lancet
Year: 2002
Tongue: English
Weight: 158 KB
Volume: 360
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(02)11402-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1084 Only colon cancer patients with Duk

1084 Only colon cancer patients with Dukes stage C benefit from adjuvant chemotherapy with 5-fluorouracil and levamisole among 425 patients with operable colorectal cancer in a Norwegian randomised study

✍ Dahl, O.; Tveit, K.M.; Carlsen, E.; Wiig, J.N.; Myrvold, H.E.; Gauperaa, T.; Ska 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Toxicity of Oxaliplatin Plus Fluorouraci

Toxicity of Oxaliplatin Plus Fluorouracil/Leucovorin Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer: A Population-Based Study

✍ Hamza, Samia; Bouvier, Anne-Marie; Rollot, Fabien; Lepage, Côme; Faivre, Jean; B 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 254 KB

A study of gene expression markers for p

A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG)

✍ Pentheroudakis, George; Kotoula, Vassiliki; Fountzilas, Elena; Kouvatseas, Georg 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 330 KB

HER2 Overexpression as a Predictive Mark

HER2 Overexpression as a Predictive Marker in a Randomized Trial Comparing Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil with Epirubicin in Patients with Stage I/II Breast Cancer: Long-Term Results

✍ Mariantonietta Colozza; Angelo Sidoni; Anna Maria Mosconi; Antonio Cavaliere; Gi 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 890 KB

Prognostic Impact of Deficient DNA Misma

Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

✍ Sinicrope, F. A.; Mahoney, M. R.; Smyrk, T. C.; Thibodeau, S. N.; Warren, R. S.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 240 KB

Initial Biopsy Gleason Score as a Predic

Initial Biopsy Gleason Score as a Predictive Marker for Survival Benefit in Patients with Castration-resistant Prostate Cancer Treated with Docetaxel: Data from the TAX327 Study

✍ van Soest, Robert J.; de Morrée, Ellen S.; Shen, Liji; Tannock, Ian F.; Eisenber 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 378 KB